Hudson Capital Management LLC Increases Position in The Cigna Group (NYSE:CI)

Hudson Capital Management LLC increased its stake in shares of The Cigna Group (NYSE:CI) by 3.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 13,742 shares of the health services provider’s stock after purchasing an additional 429 shares during the period. Hudson Capital Management LLC’s holdings in The Cigna Group were worth $3,795,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of CI. Ulland Investment Advisors LLC lifted its position in shares of The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Prospera Private Wealth LLC acquired a new position in The Cigna Group during the third quarter worth about $37,000. ORG Wealth Partners LLC acquired a new position in The Cigna Group during the fourth quarter worth about $34,000. Harbor Capital Advisors Inc. purchased a new stake in shares of The Cigna Group in the third quarter valued at about $45,000. Finally, Intact Investment Management Inc. purchased a new stake in shares of The Cigna Group in the third quarter valued at about $69,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Piper Sandler reaffirmed an “overweight” rating and set a $394.00 price target (up previously from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. Stephens reiterated an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a research note on Friday, November 1st. Barclays raised their price target on shares of The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research report on Monday, November 4th. Finally, Royal Bank of Canada lowered their target price on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. One equities research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $395.93.

The Cigna Group Stock Performance

Shares of NYSE CI opened at $289.04 on Thursday. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The stock’s 50-day moving average is $299.16 and its 200 day moving average is $326.29. The stock has a market cap of $80.40 billion, a price-to-earnings ratio of 27.27, a P/E/G ratio of 0.78 and a beta of 0.54. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83.

The Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. During the same quarter in the previous year, the company posted $6.77 earnings per share. The Cigna Group’s revenue for the quarter was up 29.8% on a year-over-year basis. On average, sell-side analysts anticipate that The Cigna Group will post 28.5 EPS for the current fiscal year.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.